Common use of Licensed Compounds Clause in Contracts

Licensed Compounds. To Hengrui’s knowledge, neither ▇▇▇▇▇▇▇ nor any of its Affiliates (a) own or otherwise Control any Small Molecules that directly binds to and modulate Myosin II, including other regions within the sarcomere, as a primary mechanism of action, other than the Licensed Compounds, and (b) is a party to an Existing Collaboration with respect to the Exploitation of any Small Molecules that directly binds to and modulate Myosin II, including other regions within the sarcomere, as a primary mechanism of action.